Briana Barclay, MD
Obstetrics & Gynecology · Davenport, IANPI 1538110085
Payments from drug & device makers
Across 75 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$275
- Hologic Sales And Service, LLC$160
- Bayer$142
- Johnson & Johnson$105
- Coopersurgical, Inc.$95
- Biogen$87
- plus $628 from 20 others
What the payments were for
- Food & beverage$1,46198%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $275 |
| Hologic Sales And Service, LLC | 5 | $160 |
| Bayer | 9 | $142 |
| Johnson & Johnson | 3 | $105 |
| Coopersurgical, Inc. | 3 | $95 |
| Biogen | 5 | $87 |
| Exeltis, USA Inc. | 5 | $85 |
| Organon | 4 | $71 |
| Myovant Sciences Inc. | 3 | $59 |
| Axonics, Inc. | 2 | $55 |
| Astellas Pharma US Inc | 3 | $48 |
| Abbott | 2 | $44 |
| Channel Medsystems, Inc. | 1 | $35 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Applied Medical Resources Corporation | 1 | $25 |
| Merck | 2 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Octapharma USA, Inc. | 1 | $19 |
| Vertex | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Radius Health, Inc. | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Amgen | 1 | $11 |
How this compares
$1,491 in reported general payments places this provider in the 75th percentile of 274 obstetrics & gynecology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $3,463 |
| ValacyclovirValacyclovir Hcl | 19 | $337 |
| Clobetasol Propionate | 12 | $252 |
| Solifenacin Succinate | 12 | $122 |
| Alprazolam | 16 | $106 |
| Triamcinolone Acetonide | 15 | $43 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $0 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Davenport
- Kenneth NaylorDavenport$2K
- Alvadore OsbornWest Des Moines$953K
- Jack SwansonAmes$691K
- Stephanie MorganAnkeny$186K
- Jorge SotolongoCouncil Bluffs$171K
- Laura NealDubuque$157K
- Jason RexrothCedar Rapids$66K
- Stephen StyronCedar Falls$50K
- Amy BingamanDes Moines$44K
- Maxwell MageeWest Des Moines$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.